Canada's Ebola vaccine timeline

Download the alternative format
(PDF format, 241 KB, 1 page)

Organization: Public Health Agency of Canada

Date published: 2015

2002

  • Vaccine developed at the Agency's National Microbiology Laboratory
  • Patent protection

2002-2012

  • Experiments done on animals to test effectiveness

2010

  • Commercial license granted to NewLink Genetics

2013

  • One lot, approximately 1500 vials, of Ebola vaccine manufactured for research and clinical trials

2014

  • Canada donates vials of vaccine to the WHO
  • Clinical trials begin in healthy people to test for safety
  • 800 vials of the vaccine shipped to the WHO

2015

  • Clinical trials on hundreds of healthy people to test for efficacy
  • Manufacturing vials of vaccine for trials

And beyond

  • Drug regulators like Health Canada will receive application to approve the vaccine
  • Health Canada to review research data and approve if it deems it safe and effective
  • Mass manufacturing begins
Date modified: